Skip to main content
Home News Page 2

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

https://otc.duke.edu/wp-content/uploads/2023/12/invented-at-duke.2023.0286.jpg

Inventors, Assemble: The Newest Gadgets Coming Out of Duke

What do a smart toilet, an analog film app, and metamaterial computer chips have in common? They were all invented at Duke!

Read More

https://otc.duke.edu/wp-content/uploads/2023/12/stingar-forewarned.png

Forewarned partnering with IU-led OmniSOC to promote critical cybersecurity tool

Forewarned is a Duke startup created to commercialize STINGAR, a security software platform developed by Chief Information Officer Tracy Futhey and team (Duke Office of Information Technology).

Read More

https://otc.duke.edu/wp-content/uploads/2023/12/Humacyte_Logo.jpg

Humacyte Submits Biologics License Application (BLA) to U.S. FDA Seeking Approval of Human Acellular Vessel™ (HAV™) for the Treatment of Vascular Trauma

Humacyte is a Duke University start-up out of the lab of Dr. Laura Niklason (formerly Anesthesiology, SOM), co-founded with Drs. Juliana Blum and Shannon Dahl.

Read More

https://otc.duke.edu/wp-content/uploads/2023/12/neurophos-pr-featured-image.png

Neurophos Raises $7.2 Million Round to Create Super-fast, Energy-Efficient Metamaterial-Based Optical AI Chips for Data Centers

Neurophos is a metamaterial-based start-up developing optical computing chips. It was founded by PhD graduate Patrick Bowen and spun out of the lab of Professor David Smith (ECE, Pratt).

Read More

https://otc.duke.edu/wp-content/uploads/2023/12/TEN63_RGB_v2_nobackground_Logo.jpg

Ten63 Therapeutics Announces Multi-Target Drug Discovery Collaboration with Boehringer Ingelheim

Ten63 is a Duke University start-up and DCP portfolio company out of the lab of Professor Bruce Donald (Computer Science, Trinity).

Read More

https://otc.duke.edu/wp-content/uploads/2022/09/Tune-TherapeuticsTune-Therapeutics.jpeg

Tune Therapeutics Presents First Data Supporting TUNE-401: a First-in-Class Epigenetic Silencer for Hepatitis B

Tune Therapeutics is a Duke start-up and DCP portfolio company developing epigenetic editing spun out of the lab of co-founder Professor Charles Gersbach (BME, Pratt).

Read More

https://otc.duke.edu/wp-content/uploads/2023/12/invented-at-duke.2023.0253.jpg

Invented at Duke 2023 – Engineering highlights

The Pratt School of Engineering was a big participant in the 5th Annual Invented at Duke, with multiple inventors and resources. Watch the video here.

Read More

https://otc.duke.edu/wp-content/uploads/2023/11/Zeal-Logo-Primary-1.png

NexJ Health & ZealCare to Deliver Next Generation Behavior Change Solutions for Disease Management and Health Enhancement

ZealCare is a personalized health coaching platform start-up co-founded by Chancellor Emeritus Dr. Ralph Snyderman (DOM, SOM) and Assistant Professor Connor Drake (Population Health, SOM) based on tech developed at the Duke Center for Personalized…

Read More

https://otc.duke.edu/wp-content/uploads/2023/11/1-header-128.jpg

Invented at Duke 2023 showcases a bustling innovation ecosystem

Featuring inventor booths, innovation resources, and strong support in speeches from leaders, Invented at Duke 2023 caps a big year for OTC.

Read More